ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis

ClinicalTrials.gov ID: NCT02246439

Public ClinicalTrials.gov record NCT02246439. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)

Study identification

NCT ID
NCT02246439
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
RedHill Biopharma Limited
Industry
Enrollment
330 participants

Conditions and interventions

Interventions

  • Placebo Oral Tablet Drug
  • RHB-102 Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 7, 2014
Primary completion
Feb 12, 2017
Completion
Feb 15, 2017
Last update posted
Feb 19, 2019

2014 – 2017

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Kern Medical Center Bakersfield California 93311
UC Davis Sacramento California 95817
Olive View- UCLA Medical Center Sylmar California 91342
George Washington University Washington D.C. District of Columbia 20037
University of Florida Jacksonville Jacksonville Florida 32209
University of Maryland Medical Center Baltimore Maryland 21201
South Shore Hospital South Weymouth Massachusetts 02190
Henry Ford Health System Detroit Michigan 48202
Wayne State University - Sinai Grace Hospital Detroit Michigan 48235
Hennepin County Medical Center Minneapolis Minnesota 55415
Washington University - St. Louis St Louis Missouri 63110
Hackensack University Medical Center Hackensack New Jersey 07601
Kings County Hospital Brooklyn New York 11203
University Hospital of Brooklyn Brooklyn New York 11203
North Shore University Hospital Manhasset New York 11030
Cohen's Children's Medical Center of NY New Hyde Park New York 11040
Long Island Jewish Medical Center New Hyde Park New York 11040
Staten Island University Hospital North Staten Island New York 10305
Stony Brook University Stony Brook New York 11794
Oregon Health and Science University Portland Oregon 97239
University of Pennsylvania Philadelphia Pennsylvania 19104
UPMC Mercy Pittsburgh Pennsylvania 15219
University of Pittsburgh Pittsburgh Pennsylvania 15261
CityDoc Urgent Care Dallas Texas 75209
Baylor College of Medicine Houston Texas 77030
McAllen Primary Care McAllen Texas 78503

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02246439, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2019 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02246439 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →